Post-transplant lymphoproliferative disorders: Determination of donor/recipient origin in a large cohort of kidney recipients

American Journal of Transplantation

Volumn 11, Issue 6, 2011, Pages 1260-1269

  Olagne, J ^a   Caillard, S ^a   Gaub, M P ^a   Chenard, M P ^a   Moulin, B ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

FISH; kidney transplantation; microsatellites; post transplant lymphoproliferative disorders; tumoral cell origin

Indexed keywords

MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; FEMALE; GENE LOCUS; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MORTALITY; OUTCOME ASSESSMENT; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; SHORT TANDEM REPEAT; Y CHROMOSOME;

COHORT STUDIES; GRAFT VS HOST DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; TISSUE DONORS;

EID: 79958786439     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03544.x     Document Type: Article

References (48)

1. Webber SA, Naftel DC, Fricker FJ, et al,. Lymphoproliferative disorders after paediatric heart transplantation: A multi-institutional study. Lancet 2006; 367: 233-239. (Pubitemid 43107668)
2. Opelz G, Dohler B,. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004; 4: 222-230. (Pubitemid 38248525)
3. Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K,. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 2005; 80: 1233-1243. (Pubitemid 41746802)
4. Cherikh WS, Kauffman HM, McBride MA, et al,. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation 2003; 76: 1289-1293. (Pubitemid 37430713)
5. Ho M, Miller G, Atchison RW, et al,. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: The role of primary infection. J Infect Dis 1985; 152: 876-886. (Pubitemid 16236674)
6. Caillard S, Lelong C, Pessione F, Moulin B,. Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry. Am J Transplant 2006; 6: 2735-2742. (Pubitemid 44571695)
7. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL,. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985; 39: 461-472. (Pubitemid 15036441)
8. Starzl TE, Nalesnik MA, Porter KA, et al,. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984; 1: 583-587. (Pubitemid 14156511)
9. Nalesnik MA, Jaffe R, Starzl TE, et al,. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133: 173-192.
10. Petit B, Le Meur Y, Jaccard A, et al,. Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation. Transplantation 2002; 73: 265-271. (Pubitemid 34112852)
11. Ng IO, Shek TW, Thung SN, et al,. Microsatellite analysis in post-transplantation lymphoproliferative disorder to determine donor/recipient origin. Mod Pathol 2000; 13: 1180-1185.
12. Meduri G, Fromentin L, Vieillefond A, Fries D,. Donor-related non-Hodgkin's lymphoma in a renal allograft recipient. Transplant Proc 1991; 23: 2649.
13. Cherqui D, Duvoux C, Plassa F, et al,. Lymphoproliferative disorder of donor origin in a liver transplant recipient: Complete remission after drastic reduction of immunosuppression without graft loss. Transplantation 1993; 56: 1023-1026. (Pubitemid 23321552)
14. Spiro IJ, Yandell DW, Li C, et al,. Brief report: Lymphoma of donor origin occurring in the porta hepatis of a transplanted liver. N Engl J Med 1993; 329: 27-29. (Pubitemid 23182875)
15. Renoult E, Aymard B, Gregoire MJ, et al,. Epstein-Barr virus lymphoproliferative disease of donor origin after kidney transplantation: A case report. Am J Kidney Dis 1995; 26: 84-87.
16. Hjelle B, Evans-Holm M, Yen TS, et al,. A poorly differentiated lymphoma of donor origin in a renal allograft recipient. Transplantation 1989; 47: 945-948. (Pubitemid 19161825)
17. Armes JE, Angus P, Southey MC, et al,. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation. Cancer 1994; 74: 2436-2441. (Pubitemid 24320845)
18. Strazzabosco M, Corneo B, Iemmolo RM, et al,. Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients. J Hepatol 1997; 26: 926-934. (Pubitemid 27145719)
19. Hegele RG, Bicknell SG, Bailey DJ, Cameron RG,. In situ hybridization for the Y chromosome reveals a donor origin for a posttransplant lymphoproliferative disorder in a sex-mismatched hepatic allograft. Arch Pathol Lab Med 1994; 118: 795-796. (Pubitemid 24249114)
20. Lones MA, Lopez-Terrada D, Weiss LM, Shintaku IP, Said JW,. Donor origin of post-transplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization. Arch Pathol Lab Med 1997; 121: 701-706.
21. Nuckols JD, Baron PW, Stenzel TT, et al,. The pathology of liver-localized post-transplant lymphoproliferative disease: A report of three cases and a review of the literature. Am J Surg Pathol 2000; 24: 733-741. (Pubitemid 30253512)
22. Kerim S, Abele MC, Jemma C, et al,. In situ hybridization evidence of the donor origin of a post-transplant lymphoproliferative disorder. Eur J Haematol 1999; 63: 61-63. (Pubitemid 29305618)
23. Larson RS, Scott MA, McCurley TL, Vnencak-Jones CL,. Microsatellite analysis of post-transplant lymphoproliferative disorders: Determination of donor/recipient origin and identification of putative lymphomagenic mechanism. Cancer Res 1996; 56: 4378-4381. (Pubitemid 26330443)
24. Baron PW, Heneghan MA, Suhocki PV, et al,. Biliary stricture secondary to donor B-cell lymphoma after orthotopic liver transplantation. Liver Transplant 2001; 7: 62-67. (Pubitemid 32060918)
25. Mentzer SJ, Longtine J, Fingeroth J, et al,. Immunoblastic lymphoma of donor origin in the allograft after lung transplantation. Transplantation 1996; 61: 1720-1725. (Pubitemid 26242011)
26. Schlieper G, Kurschat C, Donner A, et al,. Hodgkin disease-like posttransplantation lymphoproliferative disorder of donor origin in a renal allograft recipient. Am J Kidney Dis 2006; 47: e37-e41. (Pubitemid 43255167)
27. Cheung AN, Chan AC, Chung LP, et al,. Post-transplantation lymphoproliferative disorder of donor origin in a sex-mismatched renal allograft as proven by chromosome in situ hybridization. Mod Pathol 1998; 11: 99-102. (Pubitemid 28177370)
28. Gassel AM, Westphal E, Hansmann ML, Leimenstoll G, Gassel HJ,. Malignant lymphoma of donor origin after renal transplantation: A case report. Hum Pathol 1991; 22: 1291-1293.
29. Schutt G, Engemann R, Gassel HJ, et al,. Donor-transmitted non-Hodgkin's lymphoma after renal transplantation-a case report. Transplant Proc 1993; 25: 2131-2132. (Pubitemid 23125232)
30. Rehbinder B, Wullstein C, Bechstein WO, et al,. Epstein-Barr virus-associated posttransplant lymphoproliferative disorder of donor origin after simultaneous pancreas-kidney transplantation limited to pancreas allograft: A case report. Am J Transplant 2006; 6: 2506-2511. (Pubitemid 44359443)
31. Cibeira MT, Lopez-Guillermo A, Colomer D, et al,. Diffuse large B-cell lymphoma arising from donor lymphoid cells after renal and pancreatic transplantation. Ann Hematol 2003; 82: 131-135. (Pubitemid 36700991)
32. Chadburn A, Suciu-Foca N, Cesarman E, et al,. Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. Am J Pathol 1995; 147: 1862-1870.
33. Weissmann DJ, Ferry JA, Harris NL, et al,. Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. Am J Clin Pathol 1995; 103: 748-755.
34. Gulley ML, Swinnen LJ, Plaisance KT, Jr,., Schnell C, Grogan TM, Schneider BG,. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: Implications for immune-based therapy. Transplantation 2003; 76: 959-964. (Pubitemid 37186027)
35. Swerdlow SH, Webber SA, Chadburn A, Ferry JA,. Post-transplant lymphoproliferative disorders. In:, Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Lyon, France: ARC, 2008.
36. Caillard S, Pencreach S, Braun L, et al,. Simultaneous development of lymphoma in recipients of renal transplants from a single donor: Donor origin confirmed by human leukocytes antigen staining and microsatellite analysis. Transplantation 2005; 79: 79-84. (Pubitemid 40140004)
37. Kremers WK, Devarbhavi HC, Wiesner RH, et al,. Post-transplant lymphoproliferative disorders following liver transplantation: Incidence, risk factors and survival. Am J Transplant 2006; 6: 1017-1024. (Pubitemid 44356653)
38. Abu-Elmagd KM, Mazariegos G, Costa G, et al,. Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: Improved outcomes with new outlooks. Transplantation 2009; 88: 926-934.
39. Reams BD, McAdams HP, Howell DN, et al,. Post-transplant lymphoproliferative disorder: Incidence, presentation, and response to treatment in lung transplant recipients. Chest 2003; 124: 1242-1249. (Pubitemid 37290032)
40. Godyn JJ, Hicks DG, Hsu SH, et al,. Demonstration of passenger leukocytes in a case of Epstein-Barr virus posttransplant lymphoproliferative disorder using restriction fragment length polymorphism analysis. Arch Pathol Lab Med 1992; 116: 249-252.
41. Kubit V, Sonmez-Alpan E, Zeevi A, et al,. Mixed allogeneic chimerism in lung allograft recipients. Hum Pathol 1994; 25: 408-412. (Pubitemid 24151128)
42. Le Frere-Belda MA, Martin N, Gaulard P, Zafrani ES,. Donor or recipient origin of post-transplantation lymphoproliferative disorders: Evaluation by in situ hybridization. Mod Pathol 1997; 10: 701-707. (Pubitemid 27321762)
43. Peri N, Kussick S, Bakthavatsalam R, Mitsumori L, Dighe M,. Postrenal transplant non-EBV multiple myeloma of donor origin. Am J Transplant 2006; 6: 419-422. (Pubitemid 43382181)
44. Starzl TE, Demetris AJ, Trucco M, et al,. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993; 55: 1272-1277. (Pubitemid 23183236)
45. Capello D, Rasi S, Oreste P, et al,. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients. J Pathol 2009; 218: 478-486.
46. Leblond V, Davi F, Charlotte F, et al,. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: A distinct entity? J Clin Oncol 1998; 16: 2052-2059. (Pubitemid 28265040)
47. Capello D, Berra E, Cerri M, Gaidano G,. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis. Minerva Med 2004; 95: 53-64. (Pubitemid 38667804)
48. Peterson MR, Emery SC, Yung GL, Masliah E, Yi ES,. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder following lung transplantation is more commonly of host origin. Arch Pathol Lab Med 2006; 130: 176-180. (Pubitemid 43237985)